"Prediabetes" refers to a condition of abnormal but not pathological blood sugar levels. People with "prediabetes" are considered to be at risk to develop type 2 diabetes. One in three Americans are said to be prediabetic. That is a lot of people, and it has Big Pharma salivating: $322 billion is already spent annually caring for people with diabetes and prediabetes.
The American Association of Clinical Endocrinologists (AACE) has obliged by recommending diabetes drugs for "prediabetes." It should come as no surprise that the list of the AACE's corporate sponsors includes the largest pharmaceutical companies in the world: Novo Nordisk, Merck, Sanofi, AstraZeneca, GlaxoSmithKline, Pfizer, and many others.
Some of the worst diabetes drugs have by now been taken off the market. But current diabetes drugs are still both ineffective and involve enormous risks, especially for the heart. ..read more>>>...
